NHS England offers new blood test to avoid toxic side effects of chemotherapy

Organisation: Position: Deadline Date: Location:

Certain cancer patients in England will be offered a new blood test that aims to tailor treatments to their genetics in a bid to avoid toxic side-effects, reports INews.

Test results will reveal whether a patient is more like to suffer effects, such as vomiting, diarrhoea, breathlessness and severe skin reactions, enabling them to decide whether an alternative method of treatment may be more appropriate.

Of nearly 40,000 people who undergo chemotherapy each year with a collection of drugs called fluoropyrimidines, up to 40 per cent may suffer severe reactions to their treatment, with one per cent proving fatal.

The test, which was previously only available at a small number of hospitals, is now being rolled out across the country by NHS England and NHS Improvement.

Professor Dame Sue Hill, chief scientific officer for England and senior officer for genomics at NHS England, said the rollout marks “an important moment” for how genomics can improve the safety of cancer treatments.

“As our understanding of the role our DNA plays in disease grows, we will be able to use this approach to help develop personalised treatments for other conditions and embed genomics into routine care,” she said.


Full INews report

Receive Medical Brief's free weekly e-newsletter

Related Posts

Thank you for subscribing to MedicalBrief

MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.

Thank you for taking the time to complete the form.